BioGenex Launches New Website
A global market leader in fully-automated Molecular Pathology Systems, BioGenex, launches a new website for its customer’ worldwide.
Fremont, CA, August 03, 2014 --(PR.com)-- BioGenex is excited to announce the launch of its new corporate website www.biogenex.com, which has been re-designed with a brand new look and user-friendly navigation features to enhance the customers’ experience. Visitors to the website can now register with BioGenex, search for products, request a price quote, and watch the product videos. The new website also includes the latest product information as well as a new image gallery and FAQs regarding the BioGenex products.
“This is the beginning of a new phase in our three decade old business and we look forward to serving the rapidly increasing online community with our new website. With the launch of our new website, we can get closer to our customers and better understand their requirements. We hope this will be the first step in building a significant online presence for BioGenex,” said Krishan Kalra, CEO of BioGenex.
The users visiting the new website will have access to detailed information about the various innovative instruments developed by BioGenex that are applicable for
· IHC (Immunohistochemistry)
· ISH (In Situ Hybridization)
· CISH (Chromogenic in situ hybridization)
· FISH (Fluorescent In Situ Hybridization)
· miRNA (MicroRNA)
· In Situ PCR
· Special Stains
· Multiplexing
About BioGenex
BioGenex designs, develops, and commercializes advanced fully-automated Molecular Pathology Systems for cancer diagnosis, prognosis, personalized medicine, and life science research. Our products include fully-automated instruments, nucleic acid probes, antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest reagents and instruments for life science research and diagnostics.
“This is the beginning of a new phase in our three decade old business and we look forward to serving the rapidly increasing online community with our new website. With the launch of our new website, we can get closer to our customers and better understand their requirements. We hope this will be the first step in building a significant online presence for BioGenex,” said Krishan Kalra, CEO of BioGenex.
The users visiting the new website will have access to detailed information about the various innovative instruments developed by BioGenex that are applicable for
· IHC (Immunohistochemistry)
· ISH (In Situ Hybridization)
· CISH (Chromogenic in situ hybridization)
· FISH (Fluorescent In Situ Hybridization)
· miRNA (MicroRNA)
· In Situ PCR
· Special Stains
· Multiplexing
About BioGenex
BioGenex designs, develops, and commercializes advanced fully-automated Molecular Pathology Systems for cancer diagnosis, prognosis, personalized medicine, and life science research. Our products include fully-automated instruments, nucleic acid probes, antibodies, detection systems, ancillary reagents, and consumables to provide the total solution for ISH, CISH, IHC, SS, FISH, and in Situ PCR. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest reagents and instruments for life science research and diagnostics.
Contact
BioGenex
Joan Gilbert
+1-510-824-1400
www.biogenex.com
Joan Gilbert
+1-510-824-1400
www.biogenex.com
Contact
Categories